Toward the Development of a Manufacturing Process for Milvexian: Scale-Up Synthesis of the Side Chain

被引:2
|
作者
Wagschal, Simon [1 ]
Broggini, Diego [1 ]
Cao, Trung D. C. [1 ]
Schleiss, Pascal [1 ]
Paun, Kristian [1 ]
Steiner, Jessica [1 ]
Merk, Anna-Lena [1 ]
Harsdorf, Joachim [1 ]
Fiedler, Winfried [1 ]
Schirling, Stefan [1 ]
Hock, Sven [1 ]
Strittmatter, Tobias [1 ]
Dijkmans, Jan [2 ]
Vervest, Ivan [2 ]
Van Hoegaerden, Tim [2 ]
Egle, Brecht [2 ]
Mower, Matthew P. [2 ]
Liu, Zhi [3 ]
Cao, Zhiyong [3 ]
He, Xiaoning [3 ]
Chen, Lei [4 ]
Qin, Lei [4 ]
Tan, Hongyu [4 ]
Yan, Jun [4 ]
Cuniere, Nicolas Lucien [4 ,5 ]
Wei, Carolyn S. [4 ,5 ,6 ]
Vuyyuru, Venkata [7 ]
Ayothiraman, Rajaram [7 ]
Rangaswamy, Sundaramurthy [7 ]
Jaleel, Mohamed [7 ]
Vaidyanathan, Rajappa [7 ,8 ]
Eastgate, Martin D. [4 ,5 ]
Klep, Richard [2 ]
Benhaim, Cyril [2 ]
Vogels, Ilse [2 ]
Peeters, Koen [2 ]
Lemaire, Sebastien [2 ]
机构
[1] Janssen Pharmaceut, Chem Proc Res & Dev, CH-8200 Schaffhausen, Switzerland
[2] Janssen Pharmaceut, Chem Proc Res & Dev, B-2340 Beerse, Belgium
[3] Janssen China R&D Ctr, Shanghai 200030, Peoples R China
[4] Changzhou SynTheAll Pharmaceut Co Ltd, Changzhou, Jiangsu, Peoples R China
[5] Bristol Myers Squibb, Chem Proc Dev, New Brunswick, NJ 08903 USA
[6] Amgen Inc, Proc Dev, Thousand Oaks, CA 91320 USA
[7] Biocon Bristol Myers Squibb Res & Dev Ctr, Chem Dev & API Supply, Bengaluru 560099, India
[8] SEAGEN INC, 22515 29th Dr SE, Bothell, WA 98021 USA
关键词
milvexian; Suzuki; click; azide; chlorination; factor XIa inhibitor; AZIDE; METHODOLOGY; THROMBOSIS;
D O I
10.1021/acs.oprd.2c00399
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Anticoagulants play a critical role in the prevention and treatment of thrombotic-driven cardiovascular diseases. Factor XIa (FXIa) inhibitors have the potential to improve the benefit/risk profile of existing anticoagulants through a safer bleeding profile in a variety of conditions where patients are predisposed to a high risk of thrombotic or bleeding events. To support the clinical development program of milvexian (BMS-986177/JNJ-70033093), a FXIa inhibitor that recently completed phase II clinical trials, we improved the discovery route to deliver the suitable quantity of key intermediate 1 for clinical supply. This paper describes our optimization of the Suzuki cross-coupling and how we simplified and improved the isolation of 4-trimethylsilyl-1,2,3-triazole 6 after the azidation-click sequence. On top of streamlining the processes for the chlorination and demethylation steps, we demonstrated that the recrystallization of the penultimate intermediate 7 was key to control the purity and the color of the desired 4-chloro-1,2,3-triazole 1, which could be obtained in a 70% yield over five steps.
引用
收藏
页码:680 / 691
页数:12
相关论文
共 50 条
  • [31] CATALYST AND PROCESS SCALE-UP FOR FISCHER-TROPSCH SYNTHESIS
    BHATT, BL
    FRAME, R
    HOEK, A
    KINNARI, K
    RAO, VUS
    TUNGATE, FL
    TOPICS IN CATALYSIS, 1995, 2 (1-4): : 235 - 257
  • [32] CATALYST AND PROCESS SCALE-UP FOR FISCHER-TROPSCH SYNTHESIS
    BHATT, BL
    HOEK, A
    KINNARI, K
    RAO, VUS
    TUNGATE, FL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 77 - CATL
  • [33] Abscisic Acid Production: Biotechnology Process Development and Scale-up
    Aloisio, Loretta
    Lebano, Ilaria
    Servo, Emanuela
    Spera, Daniela M.
    5TH INTERNATIONAL SYMPOSIUM ON INDUSTRIAL BIOTECHNOLOGY (IBIC 2016), 2016, 49 : 133 - 138
  • [34] DEVELOPMENT AND SCALE-UP OF A PURIFICATION PROCESS FOR AN AVIAN COCCIDIOSIS VACCINE
    ADAMS, WR
    SHAMIR, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 69 - BTEC
  • [35] Peptide process development and scale-up to the multikilogram level.
    Tolle, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 21 - IEC
  • [36] CARBORANES . PROCESS DEVELOPMENT AND SCALE-UP OF 1-ISOPROPENYLCARBORANE
    FEIN, MM
    PAUSTIAN, JE
    INDUSTRIAL & ENGINEERING CHEMISTRY PROCESS DESIGN AND DEVELOPMENT, 1965, 4 (02): : 129 - &
  • [37] Process Development and Scale-Up of an Hsp90 Inhibitor
    Duan, Shengquan
    Venkatraman, Sripathy
    Hong, Xuechuan
    Huang, Kenneth
    Ulysse, Luckner
    Mobele, Bingidimi I.
    Smith, Alexander
    Lawless, Lawrence
    Locke, Andrew
    Garigipati, Ravi
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (11) : 1787 - 1793
  • [38] Process Development and Scale-up Comparisons for Transient Production of AAV
    Stadelman, Robert
    Gillmeister, Michael
    Startt, Don
    MOLECULAR THERAPY, 2020, 28 (04) : 543 - 543
  • [39] Development and scale-up of a Fab drug conjugate purification process
    Bill, Amber
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [40] Development and scale-up of a high titer cell culture process
    Ahuja, Sanjeev
    Bui, Thoa
    Chen, Jianxin
    Chen, John
    Dorotheo, Ralph
    Jain, Shilpa
    Lee, Allison
    Russell, Brian
    Singh, Shailendra
    Qu, Limin
    Venkat, Raghavan
    Ram, Kripa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241